New treatment for multidrug-resistant TB shows 85% effectiveness
New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many
New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many
Just five steps are enough to gain control of the nation’s COVID-19 outbreak and head off a return to the complete lockdowns
When the COVID-19 pandemic prompted Harvard Medical School (HMS) to move learning online in March, faculty moved swiftly, developing new curriculum approaches,
This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer
This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer
This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer
This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer
JUUL and similar pod-based e-cigarettes’ efficient delivery of nicotine may foster greater dependence than other types of e-cigarettes, according to a new
This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer
In a new report published by the Brookings Institution, Matthew Fiedler, Ph.D. ’13 , a fellow in economic studies at the USC-Brookings